Kamlesh Yadav

Biography

Dr. Yadav has been engaged in research in both the fields of Engineering and Medicine for the past 20 years both in academic and industrial settings. He has carried out seminal studies in the field of cell-signaling, especially focused on the RAS-MAPK pathway. He was one of the first in the field to develop large-molecule inhibitors to inactivate the RAS oncogene (Nature Genetics 2007, PNAS 2010, Nature Chemical Biology 2011, Nature Structural and Molecular Biology 2016, Patent WO2012122059A1).

Another aspect of his research focuses on studying various aspects of oncology (specifically prostate cancer). These include its biology, prognosis, and therapy, in order to develop new biomarkers for personalized diagnosis and treatment. With his industrial training in digital health, he has also contributed extensively in clinical data mining, and genomic data analysis. (Cell 2019, JCEU 2019, J of Urology 2019, Cancer Reports 2018, eLife 2018, J of Urology 2018, Translational Oncology 2017 and Oncotarget 2016).